http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007118585-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2826 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
| filingDate | 2005-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2007118585-A |
| titleOfInvention | MEDICINAL FORM WITH DELAY OF MEDICINES FOR TREATMENT OF INSOMNIA |
| abstract | 1. A standard (single-component) dose of a drug useful in treating insomnia, consisting of a dosage form containing said drug substance adapted to release said drug substance after a delay time during which there is essentially no drug release and which is approximately at least at least one hour after administration of the dosage form, where upon administration of the specified standard dose, the release of the drug substance p There is no substantive evidence during the indicated delay time. 2. The standard dose according to claim 1, where the delay time is from 1 to 4 hours. 3. The unit dose of claim 1, wherein less than 10% of the drug substance is released during the delay time. The unit dose of claim 1, wherein the release of said drug substance from the dosage form is pH independent. The unit dose of claim 1, wherein said dosage form is adapted to provide controlled release of said drug substance in vitro as measured using a USP stirring method (type II apparatus) at 100 rpm in 1000 ml of aqueous medium such that for the specified delay time is released no more than 10% of the specified medicinal substance. 6. The unit dose of claim 5, wherein said dosage form is adapted to provide a controlled release of said drug substance in vitro as measured using a USP agitation method (type II apparatus) at 100 rpm in 1000 ml of aqueous medium such that for specified delay time � |
| priorityDate | 2004-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.